LUIS GONZAGA PAZ-ARES RODRÍGUEZ-rekin lankidetzan egindako argitalpenak (6)

2018

  1. Analysis of response rate with ANTI-PD1/PDL-1 monoclonal antibodies in advanced solid tumors: A meta-analysis of randomized clinical trials

    Oncotarget, Vol. 9, Núm. 9, pp. 8706-8715

2017

  1. Strategies to design clinical studies to identify predictive biomarkers in cancer research

    Cancer Treatment Reviews, Vol. 53, pp. 79-97

2013

  1. Erratum: The role of pharmacogenomics in metastatic renal cell carcinoma (Cancer and Metastasis Reviews (2012) 31:SUPPL. 1 (S29-S32) DOI: 10.1007/s10555-012-9356-x)

    Cancer and Metastasis Reviews

2012

  1. The role of pharmacogenomics in metastatic renal cell carcinoma

    Cancer and Metastasis Reviews, Vol. 31, pp. S29-S32

2010

  1. Update from the Spanish Oncology Genitourinary Group on the treatment of advanced renal cell carcinoma: Focus on special populations

    Cancer and Metastasis Reviews, Vol. 29, Núm. SUPPL. 1

  2. Updated recommendations from the Spanish Oncology Genitourinary Group on the treatment of advanced renal cell carcinoma

    Cancer and Metastasis Reviews, Vol. 29, Núm. SUPPL. 1